Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02).
Saved in:
| Title: | Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02). |
|---|---|
| Authors: | Yuan H; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China., Li Z; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Cao GS; Department of Intervention, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China., Xu F; Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Wu G; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Ding PX; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Wei QL; Department of Minimal-Invasive Intervention, Anyang Tumor Hospital/The Forth Affiliated Hospital of Henan University of Science and Technology, Anyang, China., Chang ZK; Department of Interventional Therapy, Xinxiang Central Hospital/the Fourth Clinical College of Xinxiang Medical University, Xinxiang, China., Xing C; Department of Interventional Therapy, Zhoukou Central Hospital, Zhoukou, China., Niu HZ; Department of lnterventional Radiology, The First Afiliated Hospital of Henan Science and Techology University, Luoyang, China., Yin J; Department of lnterventional Radiology, Xinyang Central Hospital, Xinyang, China., Yao QJ; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China., Zheng L; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China., Xiao JC; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China., Chen CS; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China., Cheng HT; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China., Zong DW; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China., Xia WL; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China., Geng X; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China., Zhao XH; Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China., Li HL; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China., Hu HT; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Jul 03; Vol. 15, pp. 1615911. Date of Electronic Publication: 2025 Jul 03 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40678062 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yuan+H%22">Yuan H</searchLink>; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Li+Z%22">Li Z</searchLink>; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Cao+GS%22">Cao GS</searchLink>; Department of Intervention, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Xu+F%22">Xu F</searchLink>; Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wu+G%22">Wu G</searchLink>; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Ding+PX%22">Ding PX</searchLink>; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Wei+QL%22">Wei QL</searchLink>; Department of Minimal-Invasive Intervention, Anyang Tumor Hospital/The Forth Affiliated Hospital of Henan University of Science and Technology, Anyang, China.<br /><searchLink fieldCode="AU" term="%22Chang+ZK%22">Chang ZK</searchLink>; Department of Interventional Therapy, Xinxiang Central Hospital/the Fourth Clinical College of Xinxiang Medical University, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Xing+C%22">Xing C</searchLink>; Department of Interventional Therapy, Zhoukou Central Hospital, Zhoukou, China.<br /><searchLink fieldCode="AU" term="%22Niu+HZ%22">Niu HZ</searchLink>; Department of lnterventional Radiology, The First Afiliated Hospital of Henan Science and Techology University, Luoyang, China.<br /><searchLink fieldCode="AU" term="%22Yin+J%22">Yin J</searchLink>; Department of lnterventional Radiology, Xinyang Central Hospital, Xinyang, China.<br /><searchLink fieldCode="AU" term="%22Yao+QJ%22">Yao QJ</searchLink>; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Zheng+L%22">Zheng L</searchLink>; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Xiao+JC%22">Xiao JC</searchLink>; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Chen+CS%22">Chen CS</searchLink>; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Cheng+HT%22">Cheng HT</searchLink>; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Zong+DW%22">Zong DW</searchLink>; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Xia+WL%22">Xia WL</searchLink>; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Geng+X%22">Geng X</searchLink>; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhao+XH%22">Zhao XH</searchLink>; Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Li+HL%22">Li HL</searchLink>; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Hu+HT%22">Hu HT</searchLink>; Department of Interventional Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Jul 03; Vol. 15, pp. 1615911. <i>Date of Electronic Publication: </i>2025 Jul 03 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40678062 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2025.1615911 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1615911 Titles: – TitleFull: Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yuan H – PersonEntity: Name: NameFull: Li Z – PersonEntity: Name: NameFull: Cao GS – PersonEntity: Name: NameFull: Xu F – PersonEntity: Name: NameFull: Wu G – PersonEntity: Name: NameFull: Ding PX – PersonEntity: Name: NameFull: Wei QL – PersonEntity: Name: NameFull: Chang ZK – PersonEntity: Name: NameFull: Xing C – PersonEntity: Name: NameFull: Niu HZ – PersonEntity: Name: NameFull: Yin J – PersonEntity: Name: NameFull: Yao QJ – PersonEntity: Name: NameFull: Zheng L – PersonEntity: Name: NameFull: Xiao JC – PersonEntity: Name: NameFull: Chen CS – PersonEntity: Name: NameFull: Cheng HT – PersonEntity: Name: NameFull: Zong DW – PersonEntity: Name: NameFull: Xia WL – PersonEntity: Name: NameFull: Geng X – PersonEntity: Name: NameFull: Zhao XH – PersonEntity: Name: NameFull: Li HL – PersonEntity: Name: NameFull: Hu HT IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 07 Text: 2025 Jul 03 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
